| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 188, 473-478, Copyright © 1993 by Radiological Society of North America
ARTICLES |
R Gilles, JM Guinebretiere, LG Shapeero, A Lesnik, G Contesso, D Sarrazin, J Masselot and D Vanel
Department of Radiology, Institut Gustave Roussy, Villejuif, France.
Local relapse was suspected in 26 women treated conservatively for breast cancer. All women underwent routine magnetic resonance (MR) imaging and a dynamic MR subtraction study after injection of gadolinium-tetraazacyclododecanetetra-acetic acid. Twelve women had no local relapse. Surgical biopsy enabled confirmation of recurrence in 14 patients. Routine MR imaging did not allow differentiation of recurrence from glandular or scar tissue. Except for one case of fat necrosis, patients without local relapse showed no contrast enhancement 1 minute 34 seconds after injection. At dynamic MR imaging, all recurrences showed contrast enhancement 1 minute 34 seconds after injection. Nodular enhancement (n = 11) was found in invasive carcinoma, whereas linear enhancement was seen in intraductal carcinoma (n = 3). Subtraction of precontrast from postcontrast images always allowed better visualization of contrast enhancement. Contrast-enhanced subtraction dynamic MR imaging may prove to be accurate in diagnosis of local relapses of breast cancer.
This article has been cited by other articles:
|
|
 |
|
  C. K. Kuhl Current Status of Breast MR Imaging * Part 2. Clinical Applications Radiology, September 1, 2007; 244(3): 672 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kuhl The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice Radiology, August 1, 2007; 244(2): 356 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Moy, F. Ponzo, M. E. Noz, G. Q. Maguire Jr., A. D. Murphy-Walcott, A. E. Deans, M. T. Kitazono, L. Travascio, and E. L. Kramer Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets J. Nucl. Med., April 1, 2007; 48(4): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Atri New Technologies and Directed Agents for Applications of Cancer Imaging J. Clin. Oncol., July 10, 2006; 24(20): 3299 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Malich, D. R. Fischer, S. Wurdinger, J. Boettcher, C. Marx, M. Facius, and W. A. Kaiser Potential MRI Interpretation Model: Differentiation of Benign from Malignant Breast Masses Am. J. Roentgenol., October 1, 2005; 185(4): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pediconi, C. Catalano, R. Occhiato, F. Venditti, F. Fraioli, A. Napoli, M. A. Kirchin, and R. Passariello Breast Lesion Detection and Characterization at Contrast-enhanced MR Mammography: Gadobenate Dimeglumine versus Gadopentetate Dimeglumine Radiology, October 1, 2005; 237(1): 45 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Delille, P. J. Slanetz, E. D. Yeh, D. B. Kopans, E. F. Halpern, and L. Garrido Hormone Replacement Therapy in Postmenopausal Women: Breast Tissue Perfusion Determined with MR Imaging--Initial Observations Radiology, April 1, 2005; 235(1): 36 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hylton Magnetic Resonance Imaging of the Breast: Opportunities to Improve Breast Cancer Management J. Clin. Oncol., March 10, 2005; 23(8): 1678 - 1684. [Full Text] [PDF]
|
|
|
|
|
|
E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer Am. J. Roentgenol., March 1, 2005; 184(3): 868 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Devon, M. A. Rosen, C. Mies, and S. G. Orel Breast Reconstruction with a Transverse Rectus Abdominis Myocutaneous Flap: Spectrum of Normal and Abnormal MR Imaging Findings RadioGraphics, September 1, 2004; 24(5): 1287 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R Padhani MRI for assessing antivascular cancer treatments Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Morakkabati, C. C. Leutner, A. Schmiedel, H. H. Schild, and C. K. Kuhl Breast MR Imaging during or Soon after Radiation Therapy Radiology, December 1, 2003; 229(3): 893 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Jacobs, P. B. Barker, D. A. Bluemke, C. Maranto, C. Arnold, E. H. Herskovits, and Z. Bhujwalla Benign and Malignant Breast Lesions: Diagnosis with Multiparametric MR Imaging Radiology, October 1, 2003; 229(1): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Esserman, E. Kaplan, S. Partridge, D. Tripathy, H. Rugo, J. Park, S. Hwang, H. Kuerer, D. Sudilovsky, Y. Lu, et al. MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer Ann. Surg. Oncol., July 1, 2001; 8(6): 549 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Orel and M. D. Schnall MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer Radiology, July 1, 2001; 220(1): 13 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Padhani, A. D. MacVicar, C. J. Gapinski, D. P. Dearnaley, G. J. M. Parker, J. Suckling, M. O. Leach, and J. E. Husband Effects of Androgen Deprivation on Prostatic Morphology and Vascular Permeability Evaluated with MR Imaging Radiology, February 1, 2001; 218(2): 365 - 374. [Abstract] [Full Text]
|
|
|
|
|
|
U. Fischer, L. Kopka, and E. Grabbe Breast Carcinoma: Effect of Preoperative Contrast-enhanced MR Imaging on the Therapeutic Approach Radiology, December 1, 1999; 213(3): 881 - 888. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
